News

Media Coverage

  • Freezing of federal grants causes concern at NU medical school

    Susan Quaggin, MD, Chair of Department of Medicine at Northwestern University Feinberg School of Medicine, joins Lisa Dent to discuss concerns over federal funding being frozen by the Trump administration. Dr. Quaggin shares that across the entirety of Northwestern University, nearly 1,300 grants have been frozen, with 400 grants being frozen in the Department of…

  • Turnaround Month In U.S. OD Death Crisis Pinpointed By Researchers

    The turning point in America’s drug overdose (OD) crisis came in August 2023, a new study says. OD death rates are now in a sustained slow down after two decades of increase, researchers said. “This is an unprecedented shift in the modern drug crisis,” lead researcher Lori Post, PhD, director of the Buehler Center for…

  • How Trump Blew Up Northwestern’s Business Model

    In April, Northwestern University cardiologist Rod Passman, MD learned the National Institutes of Health had abruptly halted funding for a $37 million trial testing a new way to treat dangerous heart arrhythmias, with about 1,500 patients already enrolled. It was part of a universitywide funding freeze that threatened to stall hundreds of projects, including clinical…

  • AI Can Boost Radiologists’ Efficiency Without Sacrificing Accuracy

    Artificial intelligence (AI) can boost radiologists’ ability to quickly and accurately assess people’s X-rays, a new study says. Some radiologists became 40% more efficient at reviewing images with the help of a custom-built AI program, researchers reported June 5 in JAMA Network Open. “This is, to my knowledge, the first use of AI that demonstrably…

  • Menopause drug might prevent breast cancer and treat hot flashes, research finds

    A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly reduced” breast tissue cell growth, which is a major indicator of cancer progression. A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal…

  • Common menopause medication might prevent breast cancer while treating hot flashes

    A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly reduced” breast tissue cell growth, which is a major indicator of cancer progression. A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal…

Events